Work in progressFolivue is still being built, so expect rough edges. Found a bug? Report it on the roadmap. Enjoying it? Buy me a coffee.Expect rough edges. Found a bug? Report it. Folivue is free. Want to help? Buy me a coffee.

Market snapshot

USEuropeAsiaLatin AmericaCurrenciesCryptoFutures

Dow Jones----S&P 500----Nasdaq----Russell----VIX----

Home›

Compare to

In the news

Keep browsing

You may be interested in

Help Roadmap & feedback Support Folivue Privacy Terms Disclaimer

ToolsStock return calculator Export Google Finance portfolios and watchlist to CSV

GuidesGoogle Finance classic view, rebuilt The new Google Finance, reviewed honestly The Google Finance redesign, explained A Google Finance alternative for classic users A Yahoo Finance alternative for people who miss the old one Google Finance without the AI Why did Google Finance change? Not because users asked The Google Finance portfolio: what changed, and how to keep tracking About Folivue

Folivue is not affiliated with, endorsed by or sponsored by Google LLC, Alphabet Inc., Yahoo, or any exchange or index provider. Market data comes from third parties, may be delayed or inaccurate, and is not investment advice; all other names and marks belong to their owners. Read the full disclaimer.

Market snapshot

Dow Jones0.26%53,417.16+140.15 S&P 5000.28%7,652.86-21.51 Nasdaq0.76%25,980.19-200.26 Russell0.76%2,995.08-22.79 VIX4.76%15.85+0.72

Keep browsing

You may be interested in

TSLATesla, Inc.$348.95
3.83%
AMZNAmazon.com, Inc.$262.07
1.33%
AAPLApple Inc.$310.34
0.32%
AMDAdvanced Micro Devices, Inc.$456.75
3.49%
METAMeta Platforms, Inc.$559.02
1.66%
WTFCWintrust Financial Corporation$151.99
0.45%
PBProsperity Bancshares, Inc.$72.75
0.03%
VLYValley National Bancorp$14.10
0.42%

IDNA: iShares Genomics Immunology and Healthcare ETF Price, Chart & Stats | Folivue

Home›IDNA • NYSEARCA

iShares Genomics Immunology and Healthcare ETF

$39.671.02%-0.41 Today

After Hours:$40.29(1.56%) +0.62

Closed: Aug 24, 4:44:59 PM UTC-4 · USD · NYSEARCA · Disclaimer

$327.801.45%2.79%

Global X Genomics & Biotechnology ETF$65.13GNOM2.46%iShares Cybersecurity and Tech ETF$62.52IHAK1.47%iShares Self-Driving EV and Tech ETF$37.06IDRV1.15%iShares Future Exponential Technologies ETF$82.09XT0.98%Invesco Biotechnology & Genome ETF$97.30PBE0.30%

In the news

StockUS listed securityUS headquartered

Previous close$40.08

Day range$39.00 - 39.84

Year range$22.12 - 40.86

Avg Volume53.51K

P/E ratio25.49

Dividend yield0.87%

Primary exchangeNYSEARCA

About

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-. The fund is non-diversified.

Stocktwits•4 days ago

Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough

Business Wire•6 days ago

Arcadia Capital Advises InformedDNA on Divestiture of Genetic Testing Utilization Management Business Unit to Zyter